Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 28

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 28
---
 per share of $10.00, for an aggregate purchase price of $15,000,000.

“PIPE Equity Subscription Agreement” means that certain Equity Subscription Agreement, dated November 30, 2022, as amended, by and among ParentCo, Iris, and PIPE Investor, as amended.

“PIPE Investor” means the accredited investor who is a party to the PIPE Equity Subscription Agreement.

“PIPE Shares” means the 1,500,000 shares of ParentCo Common Stock that PIPE Investor has committed to purchase pursuant to the PIPE Equity Subscription Agreement.

“ Pre-Closing Iris Certificate of Incorporation ” means Iris’s certificate of incorporation prior to the closing of the Business Combination.

“ Pre-Closing ParentCo Certificate of Incorporation” means ParentCo’s certificate of incorporation prior to the closing of the Business Combination.

“ private placement” means the private sale of private placement warrants that occurred simultaneously with the consummation of our IPO.

“ private placement warrants ” means each issued and outstanding non-redeemable warrant of Iris that was issued by Iris in a private placement at the time of the consummation of Iris’s IPO, entitling the holder thereof to purchase one Iris Class A Share at $11.50 per share.

“ Proposed Bylaws ” means the proposed bylaws of ParentCo on the effective date of the Business Combination attached to this proxy statement/prospectus as Annex I .

“ Proposed Organizational Documents ” means the Proposed ParentCo Certificate of Incorporation and the Proposed Bylaws.

“ Proposed ParentCo Certificate of Incorporation ” means the proposed amended and restated certificate of incorporation of ParentCo upon the effective date of the Business Combination attached to this proxy statement/prospectus as Annex C .

“ public shares” means the 174,477 shares of Iris Class A Common Stock currently outstanding at January 2, 2025, including Class A Common Stock underlying the Iris Units issued in our IPO.

“ public stockholders” means holders of public shares, including our initial stockholders to the extent our initial stockholders hold public shares, provided that our initial stockholders will be considered “public stockholders” only with respect to any public shares held by them.

“ Public Warrants ” means the 6,900,000 warrants included in the Iris Units issued in our IPO, each of which is exercisable for one share of Iris Class A Common Stock in accordance with its terms.

“ redemption rights ” means the means the right of eligible holders of Iris Class A Shares to elect to redeem all or a portion of such